With one exception, budget allocations are booming for U.S. science agencies, a CRISPR paper that shook faith has been retracted, and professional basketball teams build sensory rooms for fans on the spectrum.

A modified version of the genetic engineering tool CRISPR may restore expression of the gene mutated in fragile X syndrome.

Researchers have repurposed the gene-editing tool CRISPR to dial down a gene’s activity in select subtypes of neurons in mice.

Common genetics may help forge social ties, a nonspeaking woman with autism hosts “The Late Show,” and the mix of bacteria in the gut may relate to brain structure.

The male-dominated sex bias in autism is reversed in a related syndrome, a researcher’s gender could influence her study’s outcome, and an award-nominated ad featuring a young man with autism draws criticism.

A sweeping analysis covers evidence of regression in autism, gender dysphoria is linked to autism features, and animal models of autism receive full treatment in a special tribute.

Two new methods allow scientists to swap single bases in DNA or RNA sequences.

The agency that oversees the drug approval process in Europe is moving to Amsterdam, gene editing gets its first human trial, and a tiny sensor detects even a few oxytocin molecules in blood.

A new trick involving a virus gives the CRISPR enzyme system the ability to edit the genome of a neuron more predictably than was previously possible.

A novel method allows researchers to rapidly generate stem-cell colonies with mutations linked to autism or other conditions.